
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.45 | 0.45 | 0.00 |
Stocks | 99.55 | 99.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.86 | 20.51 |
Price to Book | 5.33 | 3.98 |
Price to Sales | 2.88 | 2.63 |
Price to Cash Flow | 16.87 | 14.17 |
Dividend Yield | 1.68 | 1.54 |
5 Years Earnings Growth | 10.82 | 11.13 |
Name | Net % | Category Average |
---|---|---|
Technology | 34.63 | 28.27 |
Healthcare | 26.12 | 12.32 |
Consumer Cyclical | 9.68 | 10.53 |
Communication Services | 8.66 | 8.59 |
Consumer Defensive | 8.36 | 6.13 |
Financial Services | 7.87 | 14.88 |
Industrials | 4.69 | 9.54 |
Number of long holdings: 45
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.26 | 387.81 | -0.16% | |
Apple | US0378331005 | 5.17 | 202.52 | +2.21% | |
Meta Platforms | US30303M1027 | 4.49 | 531.48 | -2.22% | |
Alphabet A | US02079K3059 | 4.13 | 159.07 | +1.23% | |
Visa A | US92826C8394 | 3.71 | 335.18 | +0.53% | |
Abbott Labs | US0028241000 | 3.67 | 127.96 | +0.85% | |
UnitedHealth | US91324P1021 | 3.38 | 587.06 | -2.07% | |
J&J | US4781601046 | 3.38 | 154.36 | +1.73% | |
Oracle | US68389X1054 | 3.25 | 134.64 | +1.73% | |
SAP | DE0007164600 | 3.18 | 230.225 | +0.62% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GMO Quality III | 3.06B | -1.01 | 11.51 | 13.89 | ||
GMO Quality VI | 3B | -0.98 | 11.61 | 14.00 | ||
GMO Implementation | 1.87B | 5.02 | 8.32 | 3.63 | ||
GMO Benchmark-Free III | 1.08B | 5.44 | 7.90 | 4.46 | ||
GMO Benchmark-Free Allocation III | 730.69M | 4.71 | 7.28 | 3.54 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review